196 related articles for article (PubMed ID: 29264626)
1. Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
Tamimi I; Nicolau B; Eimar H; Arekunnath Madathil S; Kezouh A; Karp I; Tamimi F
Osteoporos Int; 2018 Apr; 29(4):849-857. PubMed ID: 29264626
[TBL] [Abstract][Full Text] [Related]
2. Association Between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease.
Won DY; Byun SJ; Jeong JS; Shin JY
J Am Med Dir Assoc; 2020 Aug; 21(8):1128-1133.e1. PubMed ID: 31926798
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study.
Tamimi I; Ojea T; Sanchez-Siles JM; Rojas F; Martin I; Gormaz I; Perez A; Dawid-Milner MS; Mendez L; Tamimi F
J Bone Miner Res; 2012 Jul; 27(7):1518-27. PubMed ID: 22467182
[TBL] [Abstract][Full Text] [Related]
4. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
[TBL] [Abstract][Full Text] [Related]
5. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
Taipale H; Rysä J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kröger H; Hartikainen S; Tolppanen AM
Osteoporos Int; 2019 Jul; 30(7):1481-1489. PubMed ID: 30993395
[TBL] [Abstract][Full Text] [Related]
6. Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom.
Bultink IE; Harvey NC; Lalmohamed A; Cooper C; Lems WF; van Staa TP; de Vries F
Osteoporos Int; 2014 Apr; 25(4):1275-83. PubMed ID: 24297094
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.
Driessen JH; van den Bergh JP; van Onzenoort HA; Henry RM; Leufkens HG; de Vries F
Diabetes Obes Metab; 2017 Mar; 19(3):421-428. PubMed ID: 27943565
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholinesterase inhibitors and healing of hip fracture in Alzheimer's disease patients: a retrospective cohort study.
Eimar H; Perez Lara A; Tamimi I; Márquez Sánchez P; Gormaz Talavera I; Rojas Tomba F; García de la Oliva T; Tamimi F
J Musculoskelet Neuronal Interact; 2013 Dec; 13(4):454-63. PubMed ID: 24292615
[TBL] [Abstract][Full Text] [Related]
9. Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis.
Mueller C; Perera G; Hayes RD; Shetty H; Stewart R
Age Ageing; 2018 Jan; 47(1):88-94. PubMed ID: 28655175
[TBL] [Abstract][Full Text] [Related]
10. Population-based Analysis for Risk of Suicide Death in Elderly Patients after Osteoporotic Fracture: a Nested Case-Control Study.
Jang SY; Cha Y; Lee JC; Kim H; Kim KJ; Choy W
J Korean Med Sci; 2021 Sep; 36(36):e225. PubMed ID: 34519185
[TBL] [Abstract][Full Text] [Related]
11. Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.
Bours S; de Vries F; van den Bergh JPW; Lalmohamed A; van Staa TP; Leufkens HGM; Geusens PPP; Drent M; Harvey NC
Osteoporos Int; 2016 Apr; 27(4):1603-1610. PubMed ID: 26630976
[TBL] [Abstract][Full Text] [Related]
12. Fracture rate in patients with myasthenia gravis: the general practice research database.
Pouwels S; de Boer A; Javaid MK; Hilton-Jones D; Verschuuren J; Cooper C; Leufkens HG; de Vries F
Osteoporos Int; 2013 Feb; 24(2):467-76. PubMed ID: 22531999
[TBL] [Abstract][Full Text] [Related]
13. Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study.
Chen S; Price AC; Cardinal RN; Moylett S; Kershenbaum AD; Fitzgerald J; Mueller C; Stewart R; O'Brien JT
PLoS Med; 2022 Dec; 19(12):e1004124. PubMed ID: 36472984
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non-hypertensive Alzheimer's patients.
Al-Hamed FS; Kouniaris S; Tamimi I; Lordkipanidzé M; Madathil SA; Kezouh A; Karp I; Nicolau B; Tamimi F
Alzheimers Dement (N Y); 2021; 7(1):e12184. PubMed ID: 34458554
[TBL] [Abstract][Full Text] [Related]
15. Association between proton pump inhibitor use and risk of fracture: A population-based case-control study.
Kim JJ; Jang EJ; Park J; Sohn HS
PLoS One; 2020; 15(7):e0235163. PubMed ID: 32730257
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
Park JH; Song YM; Jung JH; Han K
Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
[TBL] [Abstract][Full Text] [Related]
17. Blood pro-inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors.
Richardson C; Gard PR; Klugman A; Isaac M; Tabet N
Int J Geriatr Psychiatry; 2013 Dec; 28(12):1312-7. PubMed ID: 23585364
[TBL] [Abstract][Full Text] [Related]
18. Effect of acetylcholinesterase inhibitors on post-surgical complications and mortality following a hip fracture: a cohort study.
Tamimi I; Madathil SA; Kezouh A; Nicolau B; Karp I; Tamimi F
J Musculoskelet Neuronal Interact; 2017 Jun; 17(2):69-77. PubMed ID: 28574413
[TBL] [Abstract][Full Text] [Related]
19. Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies.
Liu FL; Lin CS; Yeh CC; Shih CC; Cherng YG; Wu CH; Chen TL; Liao CC
Osteoporos Int; 2017 Nov; 28(11):3123-3133. PubMed ID: 28821915
[TBL] [Abstract][Full Text] [Related]
20. Early-onset dementia and risk of hip fracture and major osteoporotic fractures.
Matsumoto S; Hosoi T; Yakabe M; Fujimori K; Tamaki J; Nakatoh S; Ishii S; Okimoto N; Akishita M; Iki M; Ogawa S
Alzheimers Dement; 2024 May; 20(5):3388-3396. PubMed ID: 38561022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
